Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.5M-14.5% | $16.96M-46.2% | $31.51M+163% | $11.98M+396% | $2.42M-80.7% | ||
| $463K-49.8% | $923K-10.6% | $1.03M-9.0% | $1.14M+4.0% | $1.09M+4.8% | ||
| $10.88M+11.6% | $9.75M-0.6% | $9.81M-9.3% | $10.82M-6.1% | $11.52M+51.7% | ||
| $57.11M-53.6% | $123.05M+56.9% | $78.44M+8.3% | $72.44M+30.8% | $55.4M-34.6% | ||
| $270K-60.8% | $689K+266% | $188K+189% | $65K-91.9% | $798K+40.0% | ||
| $1.63M+108% | -$20.07M+35.0% | -$30.87M-959% | -$2.92M+69.9% | -$9.68M+17.7% | ||
| $7.25M-98.8% | $587.12M+3,536% | $16.15M0.0% | $16.15M0.0% | $16.15M0.0% | ||
| -$21.34M+2.2% | -$21.82M-47.3% | -$14.82M+69.4% | -$48.37M-91.7% | -$25.24M+38.9% | ||
| $37.4M-53.9% | $81.16M+148% | $32.75M+54.8% | $21.15M+3.3% | $20.48M— | ||
| $56.84M-53.5% | $122.36M+56.4% | $78.25M+8.1% | $72.37M+32.6% | $54.6M-35.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $331.0M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $329.8M over the trailing twelve months, up 60.3% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
